Cost effectiveness of nifedipine compared with atosiban in the treatment of threatened preterm birth (APOSTEL III trial)

T. A.J. Nijman, G. J. van Baaren, E. O.G. van Vliet, M. Kok, W. Gyselaers, M. M. Porath, M. Woiski, M. A. de Boer, K. W.M. Bloemenkamp, M. Sueters, A. Franx, B. W.J. Mol, M. A. Oudijk^*

^*Corresponding author for this work